Advances in Animal and Veterinary Sciences

Research Article
Adv. Anim. Vet. Sci. 9(6): 802-810
 
Figure 1

Count of Cryptosporidium cysts every other day post-infection of the groups of immunocompetent mice treated with a commercial- and home-isolated probiotics compared to the infected untreated controls. The thin vertical bars at each point refer to the standard errors of the tested samples. 

Figure 2

Count of Cryptosporidium cysts every other day post-infection of the groups of immunocompromised mice treated with a commercial- and home-isolated probiotics compared to the infected untreated controls. The thin vertical bars at each point refer to the standard errors of the tested samples.  

Figure 3

Average count of Cryptosporidium cysts over the 10-day treatment phase for infected, immunocompromised, and immunocompetent mice. The thin vertical bars at each point refer to the standard errors of the tested samples. 

Figure 4

Fit of the regression decay models to the experimental data of the commercial probiotic. R2 value is the coefficient of determination. 

Figure 5

Fit of the regression decay models to the experimental data of the isolated probiotic. R2 value is the coefficient of determination.
 

Figure 6

Treatment protocols for the immunocompetent mice compared to Nitazoxanide. The counts of Cryptosporidium spp. cysts on the days 2 and 8 post infection were calculated for the mice treated with the two probiotics using the decay model.
 

Figure 7

Treatment protocols for the immunocompromised mice compared to Nitazoxanide The counts of Cryptosporidium spp. cysts on the days 2 and 8 post infection were calculated for the mice treated with the two probiotics using the decay model.

Figure 8

Cross-sections of intestinal tissues stained with hematoxylin and eosin. A) Control group, magnification 20x. B) Infected immunocompetent mice, magnification 40x. C) Immunocompetent mice infected and treated with the commercial probiotic, magnification 10x, D) Immunocompetent mice infected and treated with home-isolated probiotics, magnification 40x. E) Infected immunocompromised mice magnification 10x. F) Immunocompromised mice infected and treated with commercial probiotic magnification 20x. G) Immunocompromised mice infected and treated with home-isolated probiotic magnification 10x. Villi (V), Lamina Propria (LP), Goblet Cells (G), Degenerated Villi (DV), Fused Villi (FV), and Cell Infiltrate (I).
 

Eq1
Eq2
Eq3
Eq4